Research

Clinical Study Results: Efficacy of vagal nerve stimulation on selected patients with intractable epilepsy

Diana Moses R.N., C.N.S., M.S., C.N.R.N.; Mark Yerby M.D., M.P.H., F.A.A.N., James Schimshock M.D.
Providence Epilepsy Services, Portland, Oregon

Vagal nerve stimulation (VNS) is an adjunctive therapy for improving seizure control in patients with epilepsy. The actual mechanism for how the VNS prevents seizures is not precisely known.

Clinical trials: ALS

View current clinical trials investigating treatments for ALS.

Clinical trials: Alzheimer’s disease

View current clinical trials investigating treatments for Alzheimer’s disease.

Clinical trials: Multiple sclerosis

Useful therapies are available for virtually every patient with multiple sclerosis. FDA-approved medications currently in use have had major beneficial impact on disease activity in many patients, but we must do better. We must develop therapies with even more potency in disease control, less potential of toxicity and improved ease of administration and patient comfort.

Clinical trials: Stroke

View current clinical trials investigating treatments for stroke.

New Emergency Treatments for Stroke

Thrombolytic or "clot-busting" drugs offer an emergency treatment option for some people who are having a stroke. These medications, which include an agent called a tissue plasminogen activator (t-PA), halt the stroke by dissolving the blood clot that is blocking blood flow to the brain.

Vascular intervention

Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy 

The Experimental treatment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)

Purpose of study: To determine if Nuedexta exerts a palliative effect on speech, swallowing and salivation in patients with ALS. Principal...